acetonitrile has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capelo, JL; Lodeiro, C; López-Fernández, H; Martins, G; Prates, J; Santos, HM | 1 |
| Bagnati, R; Cereda, R; D'Incalci, M; Livi, V; Marangon, E; Sala, F; Zucchetti, M | 1 |
2 other study(ies) available for acetonitrile and Kahler Disease
| Article | Year |
|---|---|
Modulating the protein content of complex proteomes using acetonitrile.
Topics: Acetonitriles; Aged, 80 and over; Case-Control Studies; Cluster Analysis; Diagnosis, Differential; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Principal Component Analysis; Proteome; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study.
Topics: Acetonitriles; Biphenyl Compounds; Boronic Acids; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Drug Stability; Humans; Irbesartan; Multiple Myeloma; Neoplasms; Proteasome Inhibitors; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles; Threonine | 2010 |